During the past decade, GW Research Inc conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 24 clinical trials were completed, i.e. on average, 82.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 20 clinical trials were completed. i.e. 153.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "GW Research Inc" #1 sponsor was "Allergan" with 5 trials, followed by "Phathom Pharmaceuticals, Inc." with 4 trials sponsored, "Exact Sciences Corporation" with 3 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 3 trials sponsored and "Shire" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "GW Research Inc" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator, "Sucampo AG" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "GW Research Inc" are "Gastroparesis" (5 trials), "Colorectal Cancer" (3 trials), "Diabetes Mellitus" (3 trials), "Irritable Bowel Syndrome" (3 trials) and "Chronic Idiopathic Constipation" (2 trials). Many other conditions were trialed in "GW Research Inc" in a lesser frequency.

Most popular intervention types in "GW Research Inc" are "Drug" (31 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Vonoprazan" (4 trials), "Relamorelin" (3 trials), "Lansoprazole" (2 trials) and "Oral Budesonide Suspension (OBS)" (2 trials). Other intervention names were less common.

The vast majority of trials in "GW Research Inc" are 32 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "GW Research Inc". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in GW Research Inc, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in GW Research Inc, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".